claim: fda announces covid-19 treatment acceleration program
evidence_1: accelerating the investigation of products that could potentially benefit people affected by the covid-19 pandemic is one of the fdas highest priorities.", "the us food and drug administration (fda) has launched the coronavirus treatment acceleration program to accelerate the development of treatments for coronavirus disease 2019 (covid-19).", "the us food and drug administration (fda) is prioritizing the development and review of new therapies to treat covid-19 through a recently created special emergency program titled coronavirus treatment acceleration program (ctap).", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "coronavirus (covid-19) update: fda continues to accelerate development of novel therapies for covid-19 1.")